Next Article in Journal
Reply to Comments on Proteomic Investigations of Two Pakistani Naja Snake Venom Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles. Toxins 2020, 12, 669
Previous Article in Journal
Occurrence of Methicillin-Resistant Staphylococcus spp. on Brazilian Dairy Farms that Produce Unpasteurized Cheese
 
 
Reply published on 8 December 2020, see Toxins 2020, 12(12), 781.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comments on Proteomic Investigations of Two Pakistani Naja Snake Venoms Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles. Toxins 2020, 12, 669

1
Clinical Toxicology Research Group, University of Newcastle, Callaghan, NSW 2308, Australia
2
School of Physical Sciences, University of Adelaide, Adelaide, SA 5005, Australia
*
Author to whom correspondence should be addressed.
Toxins 2020, 12(12), 780; https://doi.org/10.3390/toxins12120780
Submission received: 30 October 2020 / Accepted: 3 December 2020 / Published: 8 December 2020
(This article belongs to the Section Animal Venoms)
We read with interest the article by Manuwar et al. [1] on the proteomics of the venoms of two Pakistani Naja spp. (Cobras; Naja naja and Naja oxiana). This study identified the different toxins in two Naja venoms, classifying these toxins into known protein families. Although this may provide some useful information on the diversity of toxins in the venom, it does not provide information on the abundance of each protein family in the venoms of the snakes, as purported by Manuwar et al. The authors incorrectly equated the number of different toxins in each protein family to the abundance of each toxin/protein family in the venom. They also confuse peptide fragments (Table 1 in ref. [1]) with proteins (Tables 2 and 3 in ref. [1]), making an incorrect assessment of diversity. There is an important distinction between abundance and diversity, because the toxicity of a venom reflects the amount or abundance of a particular protein family (e.g., Three-finger toxin (3FTx)) and not the number of different 3FTxs there are in the venom (diversity).
Relative toxin abundance calculations are always an approximation and it is difficult to achieve complete accuracy. The most common method used to determine toxin abundance is to fractionate the venom chromatographically, run each fraction on a separate gel lane using Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE), identify the bands in the gel lanes (using mass spectrometry), perform densitometry on the gel (if more than one band per lane), and then measure the area under the chromatogram curve. This provides a correct estimate of the proportion of the venom made up by each of the protein families [2,3,4].
In contrast to this, the authors’ methods state that they counted the number of different toxins in each protein family and divided this by the total number of toxins in the venoms. However, the authors called this process “abundance.” Based on this definition and the authors identifying 22 different 3FTxs in the N. oxiana venom (Table 3 and Figure 3 in ref. [1]), 3FTxs made up 22/140 (16%) of the venom. Similarly, 3FTxs would therefore make up 54/365 (15%) of N. naja venom (Table 2 in ref. [1]). What is more confusing is that they, in fact, calculated the abundance from Table 1 as the number of peptide fragments created by trypsin digestion for each protein family divided by the total number of fragments. They therefore incorrectly suggested that this was the abundance of 3FTxs, where, in fact, this was the number of different 3FTx fragments in the venom.
Manuwar et al. then compared the percentage abundances from their study with the true abundance of each protein family in N. naja from India [5,6], and suggested that Naja spp. from Pakistan express quite different venom proteomes. However, the venom proteome of N. naja from Pakistan has already been published by Wong et al. [2], who showed that the venom consists of 75% 3FTx and not the 21% claimed by Manuwar or the 15% that we recalculated when using their methods. Compared to a more recently published venom proteome of N. naja from western India [5], Pakistani N. naja do possess a different venom proteome, but in the opposite way. The Pakistani populations instead express higher levels of 3FTx (75%) compared to 51% in western Indian N. naja. Previously published venom proteomes of 11 species of Naja found that the abundance of 3FTxs in Naja venom proteomes was 56% to 84% of the total venom (depending on the species) [7].
The difference between toxin abundance and toxin diversity is central to understanding differential venom toxicity and its biological and medical implications. The difference between the two is clearly demonstrated in many venoms, in which one protein family makes up most of the venom but there are only a few different toxins in that protein family. For example, the Malayan blue coral snake (Calliophis bivirgata flaviceps) possesses 23 different proteins in its venom proteome [8]. However, just one toxin (cytotoxin maticotoxin) makes up 23% of the whole venom, while nine different snake venom metalloproteases (SVMP) make up 19% of the whole venom. Using the erroneous method of Manuwar, we would instead estimate the abundance of maticotoxin as 1/23 or 4% and of SVMP as 9/23 or 39%. Another example is the sea krait Laticauda colubrina [9]. The venom proteome was found to be composed of 31 toxins of which nine were 3FTxs, which would be an abundance of 29%. However, the abundance was, in fact, estimated to be 66% of the total venom using appropriate methods.
We recommend that authors publishing results on venom proteomes need to clearly state, both in the text and in the figure captions, what their results actually represent. For ease of interpretation, it would be preferable if each sector on the pie chart gives the percentage of total venom (of each protein family) followed by the number of different toxins in brackets. The words “amounts” and “abundance” cannot be used interchangeably with “diversity” and “complexity” when they are two different things. This will only lead to confusion and incorrect conclusions when making geographic comparisons, or worse, conclusions on potential venom toxicity and antivenom production (as Manuwar et al. have done) with medical implications.

Funding

This research was funded by an National Health and Medical Research Counci Senior Research Fellowship ID1154503 for GKI.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Manuwar, A.; Dreyer, B.; Böhmert, A.; Ullah, A.; Mughal, Z.; Akrem, A.; Ali, S.A.; Schlüter, H.; Betzel, C. Proteomic investigations of two Pakistani Naja snake venoms species unravel the venom complexity, posttranslational modifications, and presence of extracellular vesicles. Toxins 2020, 12, 669. [Google Scholar] [CrossRef] [PubMed]
  2. Wong, K.Y.; Tan, C.H.; Tan, K.Y.; Quraishi, N.H.; Tan, N.H. Elucidating the biogeographical variation of the venom of Naja naja (spectacled cobra) from Pakistan through a venom-decomplexing proteomic study. J. Proteom. 2018, 175, 156–173. [Google Scholar] [CrossRef]
  3. Tan, N.H.; Wong, K.Y.; Tan, K.Y. Venomics of Naja sputatrix, the Javan spitting cobra: A short neurotoxin-driven venom needing improved antivenom neutralization. J. Proteom. 2017, 157, 18–32. [Google Scholar] [CrossRef] [PubMed]
  4. Lauridsen, L.P.; Laustsen, A.H.; Lomonte, B.; Gutiérrez, J.M. Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca. J. Proteom. 2017, 150, 98–108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Chanda, A.; Kalita, B.; Patra, A.; Senevirathne, W.D.S.T.; Mukherjee, A.K. Proteomic analysis and antivenomics study of Western India Naja naja venom: Correlation between venom composition and clinical manifestations of cobra bite in this region. Expert Rev. Proteom. 2019, 16, 171–184. [Google Scholar] [CrossRef] [PubMed]
  6. Chanda, A.; Patra, A.; Kalita, B.; Mukherjee, A.K. Proteomics analysis to compare the venom composition between Naja naja and Naja kaouthia from the same geographical location of eastern India: Correlation with pathophysiology of envenomation and immunological cross-reactivity towards commercial polyantivenom. Expert Rev. Proteom. 2018, 15, 949–961. [Google Scholar] [CrossRef]
  7. Tasoulis, T.; Isbister, G.K. A review and database of snake venom proteomes. Toxins 2017, 9, 290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Tan, K.Y.; Fung, S.Y.; Yap, M.K.K.; Leong, P.K.; Liew, J.L.; Tan, N.H. Unveiling the elusive and exotic: Venomics of the Malayan blue coral snake (Calliophis bivirgata flaviceps). J. Proteom. 2016, 132, 1–12. [Google Scholar] [CrossRef] [PubMed]
  9. Tan, C.H.; Wong, K.Y.; Tan, K.Y.; Tan, N.H. Venom proteome of the yellow-lipped sea krait, Laticauda colubrina from Bali: Insights into subvenomic diversity, venom antigenicity and cross-neutralization by antivenom. J. Proteom. 2017, 166, 48–58. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tasoulis, T.; Pukala, T.L.; Isbister, G.K. Comments on Proteomic Investigations of Two Pakistani Naja Snake Venoms Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles. Toxins 2020, 12, 669. Toxins 2020, 12, 780. https://doi.org/10.3390/toxins12120780

AMA Style

Tasoulis T, Pukala TL, Isbister GK. Comments on Proteomic Investigations of Two Pakistani Naja Snake Venoms Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles. Toxins 2020, 12, 669. Toxins. 2020; 12(12):780. https://doi.org/10.3390/toxins12120780

Chicago/Turabian Style

Tasoulis, Theo, Tara L. Pukala, and Geoffrey K. Isbister. 2020. "Comments on Proteomic Investigations of Two Pakistani Naja Snake Venoms Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles. Toxins 2020, 12, 669" Toxins 12, no. 12: 780. https://doi.org/10.3390/toxins12120780

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop